Memorial Sloan-Kettering Cancer Center signs agreement with gene regulation specialist Genomatix
Advertisement
Genomatix Software GmbH, Munich, Germany and the Memorial Sloan-Kettering Cancer Center (MSKCC), New York, signed an agreement which allows full and unlimited access to GenomatixSuite for all over 1,300 MSKCC clinical and research staff, fellows and studentsresidents and clinical fellows as well as all students at the Center.
GenomatixSuite contains databases and analysis tools centered on gene regulatory networks and pathways and plus contains the largest available database of real mammalian promoter DNA sequences. Understanding Gene regulation is pivotal for understanding causes for diseases like cancer.
"I am delighted by this set up, which was initiated and is coordinated by the profoundly well-versed MSKCC's specialist Bioinformatics Core facility. Genomatix definitely will dedicate substantial resources to strengthen this relationship. We plan for joint seminars at MSKCC in order to educate more students in the very complex area of mammalian gene regulation." says Klaus May, Director Sales & Marketing of Genomatix.
He continues:" We are working towards expansion of this agreement to all researchers of Rockefeller University and the Cornell Weill Medical College"
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
One Year of GATTEX(TM) Therapy Safely Reduces Parenteral Nutrition Dependence for Patients with Short Bowel Syndrome - Results Presented at American College of Gastroenterology Annual Meeting Show Majority of Responders Continued to Benefit from GATTEX in Phase 3-Extension Study
Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million - "This strategic acquisition is a further building block for accelerating growth in the break-through technologies of the future"
Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe
Risk of lead poisoning from urban gardening is low, new study finds
World first: Launch of Quebec registry for users of medical cannabis - MUHC researcher heads one of the largest studies ever conducted on medical cannabis
Implant-based cancer vaccine is first to eliminate tumors in mice - New approach reprograms the mammalian immune system to attack tumors body-wide
Study IDs link between sugar signaling and regulation of oil production in plants
It all adds up: Study finds forever chemicals are more toxic as mixtures - Research also finds that PFOA and PFOS are major contributors to toxicity
Affibody to publish data on therapeutic effects of Affibody molecules in a cancer model
‘Seaweed drug’ helps fight off infection - Alginates found in seaweed can combat multi-drug resistant infections
Antibiotic-releasing polymer may help eradicate joint implant infection
